YCM

Yiheng Capital Management Portfolio holdings

AUM $276M
1-Year Est. Return 10.95%
This Quarter Est. Return
1 Year Est. Return
+10.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$276M
AUM Growth
-$8.35M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
25
New
Increased
Reduced
Closed

Top Buys

1
+$7.29M
2
+$1.3M
3
+$396K
4
GBIO icon
Generation Bio
GBIO
+$276K

Top Sells

1
+$26.3M
2
+$16.5M
3
+$5.32M
4
AKRO icon
Akero Therapeutics
AKRO
+$3.2M

Sector Composition

1 Financials 29.06%
2 Consumer Discretionary 19.2%
3 Healthcare 18.43%
4 Communication Services 14.9%
5 Consumer Staples 13.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOAH
1
Noah Holdings
NOAH
$751M
$80.2M 7.22%
6,719,722
BILI icon
2
Bilibili
BILI
$11.3B
$41.2M 3.71%
1,918,564
-1,225,103
EDU icon
3
New Oriental
EDU
$8.82B
$32.3M 2.91%
598,080
JD icon
4
JD.com
JD
$46.4B
$25.7M 2.31%
787,413
+223,300
HTHT icon
5
Huazhu Hotels Group
HTHT
$11.4B
$16.6M 1.49%
488,964
-156,694
AKRO icon
6
Akero Therapeutics
AKRO
$4.3B
$16M 1.44%
299,791
-60,000
RERE
7
ATRenew
RERE
$844M
$10.5M 0.94%
3,163,117
IVA
8
Inventiva
IVA
$707M
$8.44M 0.76%
2,644,926
ACMR icon
9
ACM Research
ACMR
$2.55B
$7.26M 0.65%
280,201
VRDN icon
10
Viridian Therapeutics
VRDN
$1.88B
$6.99M 0.63%
500,261
DNLI icon
11
Denali Therapeutics
DNLI
$2.44B
$6.58M 0.59%
469,981
DBVT
12
DBV Technologies
DBVT
$465M
$6.01M 0.54%
656,309
KYMR icon
13
Kymera Therapeutics
KYMR
$4.32B
$5.35M 0.48%
122,605
SVCO
14
Silvaco Group
SVCO
$174M
$5.17M 0.47%
1,096,282
+83,950
TAL icon
15
TAL Education Group
TAL
$6.68B
$3.16M 0.28%
309,240
API
16
Agora
API
$319M
$2.03M 0.18%
533,547
+340,967
BEAM icon
17
Beam Therapeutics
BEAM
$2.61B
$1.17M 0.11%
69,058
YSG
18
Yatsen Holding
YSG
$826M
$929K 0.08%
96,328
GBIO icon
19
Generation Bio
GBIO
$44.7M
$338K 0.03%
105,527
+86,374
TOUR
20
Tuniu
TOUR
$96.9M
$265K 0.02%
314,437
PLNT icon
21
Planet Fitness
PLNT
$7.77B
– –
0
RBLX icon
22
Roblox
RBLX
$93.2B
– –
-282,338
VSAT icon
23
Viasat
VSAT
$4.85B
– –
0
ALAB icon
24
Astera Labs
ALAB
$27.2B
– –
0
ULS icon
25
UL Solutions
ULS
$15.4B
– –
0